Helen N. Pemberton
London, ENG SW36JB, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
Journal: British journal of cancer
Published: February 16, 2026
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance.
Journal: Oncogene
Published: July 29, 2021
FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
Journal: NeuroImage. Clinical
Published: November 19, 2020
A Flexible, Pooled CRISPR Library for Drug Development Screens.
Journal: The CRISPR journal
Published: October 15, 2020
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.
Journal: Scientific reports
Published: March 02, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.
Journal: Nature communications
Published: September 29, 2017
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.
Journal: Cancer discovery
Published: May 30, 2017
Modeling Therapy Resistance in BRCA1/2-Mutant Cancers.
Journal: Molecular cancer therapeutics
Published: January 30, 2017
Last Updated: 09/26/2026